Allergy Therapeutics
27
1
3
22
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
7.4%
2 terminated/withdrawn out of 27 trials
91.7%
+5.2% vs industry average
11%
3 trials in Phase 3/4
9%
2 of 22 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (27)
An Exploratory Study of PQ Grass 27600 SU
Role: lead
GRASS (Grass MATA MPL Real-world Assessment Study)
Role: lead
Phase I Trial to Evaluate VLP Peanut in Healthy and Peanut Allergic Subjects
Role: lead
Tyrosine Allergoid Paediatric and Adult Study
Role: lead
Efficacy and Safety of PQ Grass in Subjects With Seasonal Allergic Rhinitis and/or Rhinoconjunctivitis Induced by Grass Pollen
Role: lead
Effect of holoBLG on Cat Allergic Patients
Role: lead
Evaluation of Safety and Tolerability of Tyrosine Adsorbed Ragweed Pollen Allergoid With MPL (Monophosphoryl Lipid A)
Role: lead
Assessment of the Contribution of Monophosphoryl Lipid A (MPL) to a Grass Pollen Allergy Vaccine
Role: lead
Investigation of Safety+Efficacy of Different Doses of RagweedMATAMPL;Assessment of Residual Allergenicity Using Skin Prick Test
Role: lead
Different Doses of Tyrosine Adsorbed Grass Pollen Allergoid With Monophosphoryl Lipid A (MPL) in Patients Sensitized to Grass Pollen
Role: lead
Different Doses of Tyrosine Adsorbed Tree Pollen Allergoid With Monophosphoryl Lipid A (MPL) in Patients Sensitized to Tree Pollen
Role: lead
Influence of Specific Immunotherapy With Pollinex Quattro (Tree-/Grass Pollen) on Allergen-specific Immunoglobulin E (IgE) Levels
Role: lead
Dose Selection Study of Efficacy and Safety of Different Doses of Grass MATA MPL and Grass MATA Using mEECs™
Role: lead
Investigation of Efficacy and Safety of Tree MATAMPL,Tree MATA, and Placebo in Patients With Birch-Induced Seasonal Allergic Rhinitis
Role: lead
A Study of Tolerability and Safety of a New Cumulative Dose of Grass MATA MPL
Role: lead
A Study of Tolerability and Safety of Two New Doses of Grass MATA MPL
Role: lead
Induction of Immunogenicity With Different Doses of TreeMATA in Subjects Allergic to Tree Pollen
Role: lead
Assessment of Residual Allergenicity of Ragweed Pollen Allergoid With Monophosphoryl Lipid A (MPL) Using Skin Prick Testing
Role: lead
Follow-up Investigation of Efficacy of Ragweed MATAMPL,and Placebo in Patients With Ragweed-induced Seasonal Allergic Rhinitis
Role: lead
Assessment of Residual Allergenicity of Tree (Birch, Hazel, and Alder) Pollen Allergoid Using Skin Prick Testing
Role: lead